SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* BANCROFT PHILIP V (Last) (First) (Middle) THE CHUBB BUILDING, 17 WOODBOURNE AVENUE (Street) HAMILTON D0 HM 08 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Chubb Ltd [ CB ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President*
	3. Date of Earliest Transaction (Month/Day/Year) 08/09/2017
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/09/2017		M		16,638	A	$85.39	344,560	D
Common Shares	08/09/2017		S(1)		7,124	D	$148.86(2)	337,436	D
Common Shares	08/09/2017		S(1)		1,780	D	$148.86(3)	335,656	D
Common Shares	08/09/2017		S(1)		7,734	D	$148.86(4)	327,922	D
Common Shares	08/09/2017		M		13,548	A	$73.35	341,470	D
Common Shares	08/09/2017		S(1)		6,093	D	$148.86(5)	335,377	D
Common Shares	08/09/2017		S(1)		5,964	D	$148.86(6)	329,413	D
Common Shares	08/09/2017		S(1)		1,491	D	$148.85(7)	327,922	D
Common Shares	08/09/2017		M		16,863	A	$62.64	344,785	D
Common Shares	08/09/2017		S(1)		7,634	D	$148.86(8)	337,151	D
Common Shares	08/09/2017		S(1)		1,845	D	$148.85(9)	335,306	D
Common Shares	08/09/2017		S(1)		7,384	D	$148.86(10)	327,922	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to Acquire Common Shares	$85.39	08/09/2017		M			16,638	(11)	02/28/2023	Common Shares	16,638	$0.00	113,542(12)	D
Options to Acquire Common Shares	$73.35	08/09/2017		M			13,548	(13)	02/23/2022	Common Shares	13,548	$0.00	99,994(14)	D
Options to Acquire Common Shares	$62.64	08/09/2017		M			16,863	(15)	02/24/2021	Common Shares	16,863	$0.00	83,131(16)	D

Explanation of Responses:

1. Sale of Common Shares in connection with broker-assisted cashless exercise of options.

2. The Common Shares reported herein as being sold were sold at a range of between $148.74 and $149.00 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent.

3. The Common Shares reported herein as being sold were sold at a range of between $148.71 and $148.95 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent.

4. The Common Shares reported herein as being sold were sold at a range of between $148.73 and $149.01 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent.

5. The Common Shares reported herein as being sold were sold at a range of between $148.74 and $148.98 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent.

6. The Common Shares reported herein as being sold were sold at a range of between $148.71 and $149.00 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent.

7. The Common Shares reported herein as being sold were sold at a range of between $148.71 and $148.95 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent.

8. The Common Shares reported herein as being sold were sold at a range of between $148.71 and $149.02 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent.

9. The Common Shares reported herein as being sold were sold at a range of between $148.75 and $148.94 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent.

10. The Common Shares reported herein as being sold were sold at a range of between $148.71 and $149.04 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent.

11. The stock options vested in equal installments on February 28, 2014, February 28, 2015 and February 28, 2016.

12. 1,171 options of this tranche have not been exercised. Total also includes options from other tranches with different exercise prices, vesting dates and expiration dates.

13. The stock options vested in equal installments on February 23, 2013, February 23, 2014 and February 23, 2015.

14. 1,363 options of this tranche have not been exercised. Total also includes options from other tranches with different exercise prices, vesting dates and expiration dates.

15. The stock options vested in equal installments on February 24, 2012, February 24, 2013 and February 24, 2014.

16. 1,596 options of this tranche have not been exercised. Total also includes options from other tranches with different exercise prices, vesting dates and expiration dates.

Remarks:

*and Chief Financial Officer

	/s/ Samantha Froud, Attorney-in-fact	08/11/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.